|
regulation of postsynaptic density assembly
|
GO_0099151 |
[Any process that modulates the frequency, rate or extent of postsynaptic density assembly, the aggregation, arrangement and bonding together of a set of components to form a postsynaptic density.] |
|
macrophage apoptotic process
|
GO_0071888 |
[Any apoptotic process in a macrophage, a mononuclear phagocyte present in a variety of tissues.] |
|
positive regulation of postsynaptic density assembly
|
GO_0160036 |
[Any process that activates or increases the frequency, rate or extent of postsynaptic density assembly.] |
|
negative regulation of Toll receptor ligand protein activation cascade
|
GO_0160035 |
[Any process that stops, prevents or reduces the frequency, rate or extent of Toll receptor ligand protein activation cascade.] |
|
14-3-3 protein binding
|
GO_0071889 |
[Binding to a 14-3-3 protein. A 14-3-3 protein is any of a large family of approximately 30kDa acidic proteins which exist primarily as homo- and heterodimers within all eukaryotic cells, and have been implicated in the modulation of distinct biological processes by binding to specific phosphorylated sites on diverse target proteins, thereby forcing conformational changes or influencing interactions between their targets and other molecules. Each 14-3-3 protein sequence can be roughly divided into three sections: a divergent amino terminus, the conserved core region and a divergent carboxy-terminus. The conserved middle core region of the 14-3-3s encodes an amphipathic groove that forms the main functional domain, a cradle for interacting with client proteins.] |
|
TMEM240-body
|
GO_0160045 |
[A multilamellar subcellular structure formed in the cytoplasm of developing neuron, composed of Tmem240 and Emd proteins.] |
|
sulfate:chloride antiporter activity
|
GO_0160044 |
[Enables the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: chloride(in) + sulfate(out) = chloride(out) + sulfate(in).] |
|
catecholamine secretion, neurotransmission
|
GO_0160043 |
[The regulated release of catecholamine by a cell in which the catecholamine acts as a neurotransmitter.] |
|
purine nucleotide uniporter activity
|
GO_0160042 |
[Catalysis of the active transport of purine nucleotides across a membrane by a mechanism involving conformational change, where energy for active transport is derived from membrane potential if the solute is charged.] |
|
membrane potential driven uniporter activity
|
GO_0022810 |
[Enables the active transport of a solute across a membrane by a mechanism involving conformational change, where energy for active transport is derived from membrane potential if the solute is charged.] |
|
mitocytosis
|
GO_0160040 |
[A migrasome-mediated selective removal of damaged mitochondria process that maintains mitochondrion homeostasis in migrating cells.] |
|
response to epinephrine
|
GO_0071871 |
[Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an epinephrine stimulus. Epinephrine is a catecholamine that has the formula C9H13NO3; it is secreted by the adrenal medulla to act as a hormone, and released by certain neurons to act as a neurotransmitter active in the central nervous system.] |
|
cellular response to monoamine stimulus
|
GO_0071868 |
[Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a monoamine stimulus. A monoamine is any of a group of molecular messengers that contain one amino group that is connected to an aromatic ring by ethylene group (-CH2-CH2-). Monoamines are derived from the aromatic amino acids phenylalanine, tyrosine, histidine and tryptophan.] |
|
response to norepinephrine
|
GO_0071873 |
[Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a norepinephrine stimulus. Norepinephrine is a catecholamine that has the formula C8H11NO3; it acts as a hormone, and as a neurotransmitter in most of the sympathetic nervous system.] |
|
cellular response to epinephrine stimulus
|
GO_0071872 |
[Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an epinephrine stimulus. Epinephrine is a catecholamine that has the formula C9H13NO3; it is secreted by the adrenal medulla to act as a hormone, and released by certain neurons to act as a neurotransmitter active in the central nervous system.] |
|
negative regulation of cGAS/STING signaling pathway
|
GO_0160049 |
[Any process that stops, prevents or reduces the frequency, rate or extent of cGAS/STING signaling pathway.] |
|
cellular response to norepinephrine stimulus
|
GO_0071874 |
[Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a norepinephrine stimulus. Norepinephrine is a catecholamine that has the formula C8H11NO3; it acts as a hormone, and as a neurotransmitter in most of the sympathetic nervous system.] |
|
craniofacial suture closure
|
GO_0160048 |
[The process of fusing together the edges of a craniofacial suture.] |
|
regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway
|
GO_0071877 |
[Any process that modulates the frequency, rate or extent of an adenylate cyclase-inhibiting adrenergic receptor signaling pathway activity. An adrenergic receptor signaling pathway is the series of molecular signals generated as a consequence of an adrenergic receptor binding to one of its physiological ligands.] |
|
muramyl dipeptide kinase activity
|
GO_0160047 |
[Catalysis of the reaction: ATP + muramyl dipeptide = ADP + H+ + 6-O-phospho-muramyl dipeptide.] |